DE69409576D1 - Spüllösung zur intraokularen Anwendung enthaltend S-(alpha, beta-Dicarboxyethyl-)Glutathion - Google Patents

Spüllösung zur intraokularen Anwendung enthaltend S-(alpha, beta-Dicarboxyethyl-)Glutathion

Info

Publication number
DE69409576D1
DE69409576D1 DE69409576T DE69409576T DE69409576D1 DE 69409576 D1 DE69409576 D1 DE 69409576D1 DE 69409576 T DE69409576 T DE 69409576T DE 69409576 T DE69409576 T DE 69409576T DE 69409576 D1 DE69409576 D1 DE 69409576D1
Authority
DE
Germany
Prior art keywords
intraocular
glutathione
dicarboxyethyl
beta
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69409576T
Other languages
English (en)
Other versions
DE69409576T2 (de
Inventor
Shinju Ohmori
Kazumi Ogata
Hideki Tsuruoka
Takahiro Sakaue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Publication of DE69409576D1 publication Critical patent/DE69409576D1/de
Application granted granted Critical
Publication of DE69409576T2 publication Critical patent/DE69409576T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69409576T 1993-06-07 1994-06-04 Spüllösung zur intraokularen Anwendung enthaltend S-(alpha, beta-Dicarboxyethyl-)Glutathion Expired - Fee Related DE69409576T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13590993 1993-06-07

Publications (2)

Publication Number Publication Date
DE69409576D1 true DE69409576D1 (de) 1998-05-20
DE69409576T2 DE69409576T2 (de) 1998-08-13

Family

ID=15162673

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69409576T Expired - Fee Related DE69409576T2 (de) 1993-06-07 1994-06-04 Spüllösung zur intraokularen Anwendung enthaltend S-(alpha, beta-Dicarboxyethyl-)Glutathion

Country Status (8)

Country Link
US (1) US5466673A (de)
EP (1) EP0628306B1 (de)
KR (1) KR100300460B1 (de)
AT (1) ATE164999T1 (de)
CA (1) CA2123555A1 (de)
DE (1) DE69409576T2 (de)
ES (1) ES2114631T3 (de)
TW (1) TW329388B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616563A (en) * 1992-12-07 1997-04-01 University Of Maryland Baltimore Campus Glutathione N-hydroxycarbamoyl thioesters and method of inhibiting neoplastic growth
US6495598B1 (en) 1997-04-22 2002-12-17 Ophtecs Corporation Perfusate preparation for ophthalmic operation
US10420736B2 (en) * 2015-09-30 2019-09-24 Tohoku University Antioxidizing intraocular perfusion solution

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS638337A (ja) * 1986-06-30 1988-01-14 Senjiyu Seiyaku Kk 抗血液凝固剤
US4837021A (en) * 1986-12-31 1989-06-06 Laboratoires P.O.S. Two part tissue irrigating solution
JPH02255624A (ja) * 1989-03-29 1990-10-16 Senjiyu Seiyaku Kk 血小板凝集抑制剤
TW207498B (de) * 1991-02-27 1993-06-11 Senju Pharma Co

Also Published As

Publication number Publication date
TW329388B (en) 1998-04-11
EP0628306A1 (de) 1994-12-14
ATE164999T1 (de) 1998-05-15
KR950000140A (ko) 1995-01-03
ES2114631T3 (es) 1998-06-01
CA2123555A1 (en) 1994-12-08
KR100300460B1 (ko) 2001-11-22
DE69409576T2 (de) 1998-08-13
US5466673A (en) 1995-11-14
EP0628306B1 (de) 1998-04-15

Similar Documents

Publication Publication Date Title
ATE227576T1 (de) Prostaglandinderivate zur behandlung des grünen stars oder einer okularen hypertension
EA199900811A1 (ru) Композиция для офтальмологических хирургических операций (варианты) и способ их осуществления
ATE286880T2 (de) Verwendung von fluprostenolisopropylester zur herstellung eines arzneimittels zur behandlung von glaukom und okularer hypertension
WO1992021049A1 (en) Methods and compositions for inhibiting deposit formation on contact lenses
DE69705643D1 (de) Anwendungen des nervenwachstumfaktors zur aufbewahrung, kultivierung oder behandlung von cornea
DE69409576D1 (de) Spüllösung zur intraokularen Anwendung enthaltend S-(alpha, beta-Dicarboxyethyl-)Glutathion
DE69501359D1 (de) Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina
WO1999044624A3 (en) Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy
IT1196423B (it) Benzotiazolin-composti
DE69518706D1 (de) Verwendung von Diphenylethanderivaten zur Herstellung eines Arzneimittels zur Behandlung von Glaukom
DE69400591D1 (de) Zusammensetzung zur intraokularen Benetzung und zur Präservierung herauspräparierter Augäpfel
DE60000736D1 (de) Miotische wirkstoffe und hypertonische wirkstoffe enthaltende ophthalmische zusammensetzungen
DE60027878D1 (de) Verwendung des nervenwachstumfaktors zur herstellung eines arzneimittels zur behandlung von erkrankungen der innenaugegeweb
ATE147755T1 (de) Dipeptidderivate und diese als aktive bestandteile enthaltendes prophylaktisches oder therapeutisches mittel gegen knochenkrankheiten
KR970704462A (ko) 각막치료제(corneal therapeutic agent)
TW263436B (en) Intraocular irrigating and enucleated eyeball preservative composition
ATE158719T1 (de) Verwendung von hexetidin oder dessen derivaten oder salzen zur herstellung einer pharmazeutischen zusammensetzung für ophthalmische verwendung
ATE250413T1 (de) 2-aminotetraline zur behandlung von glaukom
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
ATE58141T1 (de) 1-hydroxy-5-oxo-5h-pyrido(3,2-a>-phenoxazin-3carbons|ureester.
ATE81466T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.
KR890001555A (ko) 요산 배설용 조성물
RU98112504A (ru) Способ лечения вторичной глаукомы

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee